Thorax, the official journal of the British Thoracic Society, publishes influential clinical and experimental research in respiratory medicine, paediatrics, immunology, pharmacology, pathology, and surgery. The focus is on work that advances scientific understanding and impacts clinical practice. http://thorax.bmj.com/ * The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.
Better asthma control, half of the carbon footprint with climate-friendly inhalers
In this podcast, Rachael Moses, Multimedia Editor of Thorax BMJ, is joined by Professor Ashley Woodcock, Manchester Academic Health Sciences Centre, The University of Manchester, UK, to discuss the paper "Effects of switching from a metered dose inhaler to a dry powder inhaler on climate emissions and asthma control: post-hoc analysis."
This paper was a secondary analysis of the Salford Lung Study in Asthma. In a real world study SLS asthma showed that a once daily combination treatment in a dry powder inhaler improved asthma control over one year, versus usual treatment. This secondary analysis looked at the impact on carbon footprint for those patients switching from a pressurised MDI to DPI treatment.
What are the risks from 'aerosol-generating procedures’ in the treatment of patients with COVID-19?
Do hospitalised COVID-19 patients receiving treatment with CPAP and HFNOT present a significant added risk of viral contamination to the surrounding environment used by healthcare workers?
And is there enough evidence to suggest or recommend levels of PPE that should be used for healthcare workers caring for patients on CPAP or HFNOT?
Two of the main questions this short podcast addresses. Rachael Moses, Multimedia Editor Thorax BMJ, interviews Dr Chris Green, Consultant in Infectious Diseases & General (Internal) Medicine, University Hospitals Birmingham NHS Foundation Trust.
Read the two related papers:
SARS-CoV-2 environmental contamination from hospitalised patients with COVID-19 receiving aerosol-generating procedures - https://thorax.bmj.com/content/early/2021/11/01/thoraxjnl-2021-218035
Coughs and sneezes spread diseases: but do ‘aerosol generating’ procedures? - https://thorax.bmj.com/content/early/2021/11/10/thoraxjnl-2021-218133
Cigarettes and COVID-19: clearing the smoke
In this podcast, Rachael Moses, Multimedia Editor of Thorax BMJ, talks to Dr Ash Clift Nuffield Department of Primary Care Health Sciences, University of Oxford.
The evidence surrounding COVID-19 has been conflicting and inconsistent. This podcast discusses the findings of this observational and Mendelian randomisation study using the UK Biobank cohort. The author discusses the findings with regards to the potential causal effect of cigarette smoking on the severity of COVID-19 infection and what this means for both the public and clinicians.
Related article: https://thorax.bmj.com/content/thoraxjnl/early/2021/09/12/thoraxjnl-2021-217080
Do financial incentives improve key COPD outcomes?
In this podcast, we discuss the impact of Best Practice Tariffs (BPT) in improving outcomes for people with COPD admitted to hospital following an acute exacerbation. The key question was to understand if the combination of specialist review within 24 hours and a discharge care bundle incentivised by the English COPD BPT scheme was associated with improved mortality and readmission rates for those admitted with an acute exacerbation of COPD.
Thorax Multimedia Editor, Rachael Moses, talks to Philip Stone, from the National Heart and Lung Institute, Imperial College London, UK.
Read the paper (https://thorax.bmj.com/content/early/2021/07/15/thoraxjnl-2021-216880) and subscribe to the Thorax Podcast on your favourite platform.
The BCG Vaccine Programme: Are we getting it right?
In this podcast, Rachael Moses, Multimedia Editor of Thorax BMJ, talks to Professor James Trauer, Epidemiological Modelling Unit, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
Tuberculosis is the world’s leading infectious disease killer with the BCG vaccine being the only approved vaccine for its control. The paper on hand was a systematic review of studies looking at the effect of BCG vaccination on TB disease, including sub-categories of TB disease. They discuss what makes this review different and the potential implications of the findings.
Read the related articles: https://thorax.bmj.com/content/early/2021/05/18/thoraxjnl-2020-216794
Sleep Vibrations: Can a positional therapy device improve outcomes in obstructive sleep apnoea?
In this podcast Rachael Moses, MultiMedia Editor Thorax BMJ talks to Ms Laura Hidalgo Armas, OSI Araba Hospital University, Vitoria, Spain. They discuss the effectiveness of a new vibrational positional device located on the forehead on reducing the apnea-hypopnea index and total sleep time in the supine position for patients with obstructive sleep apnea.
Links to related papers: https://thorax.bmj.com/content/early/2021/04/21/thoraxjnl-2020-216167
Quality Pulmonary Medicine Podcast
I find the study selection excellent and the easy CPD which fits into any commute amazingly helpful.